Clinical trials

  • icotrokinra for Inflammatory conditions
  • DS101 for Diabetic retinopathy
  • CISPLATIN for HPV-positive oropharyngeal squamous cell carcinoma
  • (chemical described in product record) for Non-small cell lung cancer|RAS‑mutated non-small cell lung cancer
  • pembrolizumab for Non-small cell lung cancer
  • RIMEGEPANT SULFATE for Chronic migraine
  • PERFLUBUTANE for Focal liver lesion
  • DEXAMFETAMINE SULFATE, PIRACETAM for Cocaine use disorder
  • TREPROSTINIL PALMITIL for Pulmonary arterial hypertension
  • 3-(4-METHYLPIPERAZINE-1-CARBONYL)-7-OXABICLO[2.2.1]HEPTANE-2-CARBOXYLIC ACID for Microsatellite stable colorectal cancer
  • ACICLOVIR for Herpes simplex virus oropharyngeal reactivation
  • GALLIUM (68GA), PENTIXAFOR for Primary aldosteronism | Primary hyperaldosteronism